Keyphrases
Acute Myeloid Leukemia
98%
AML1-ETO
15%
Benzodiazepines
15%
Braking Mechanism
31%
C-X-C Chemokine Receptor Type 4 (CXCR4)
15%
CBFβ
51%
Cell Survival
31%
CHD7
31%
Chromodomain Helicase DNA-binding Proteins
9%
Confidence Interval
9%
Core Binding Factor beta
19%
Core Binding Factor Leukemia
15%
Core-binding Factor
22%
Delivery Vehicle
15%
Drug Discovery
15%
Factor Interaction
15%
FBXO9
15%
GATA2 mutation
15%
Genomic Profiling
15%
Geriatric Assessment
15%
Hematopoietic Differentiation
15%
Histone Deacetylase 1 (HDAC1)
15%
IL1RL1
33%
Intensive Chemotherapy
9%
Interleukin-33 (IL-33)
19%
Inversion 16
31%
Knock-in Mouse Model
24%
Leukemia
14%
Leukemia Cells
17%
Leukemia Stem Cells
15%
Leukemogenesis
19%
Low-dose Chemotherapy
9%
LXCXE
15%
MicroRNA
15%
Mitochondrial Metabolism
15%
Multi-omics
15%
MYH11
55%
Myosin Heavy Chain (MyHC)
8%
Older Adults
15%
P38 MAPK Pathway
15%
PAX5
15%
Putative Drug Targets
15%
Runt-related Transcription Factor 1 (RUNX1)
57%
RUNX1-RUNX1T1
15%
Small Interfering RNA (siRNA)
15%
Small Interfering RNA (siRNA) Delivery
15%
SMMHC
31%
Synthetic Immunotherapy
15%
Therapy Selection
15%
United States of America
15%
Biochemistry, Genetics and Molecular Biology
Allele
19%
Benzodiazepine
15%
Binding Affinity
15%
Binding Domain
6%
C-Terminus
15%
Cell Cycle
5%
Cell Proliferation
5%
CHD7
15%
Chromodomain
25%
Chromosome 16
15%
Core Binding Factor
15%
Core Binding Factor Beta
41%
DNA-binding Protein
25%
Fusion Gene
8%
Fusion Protein
18%
GATA2
15%
Gene Expression
5%
Genetics
6%
HDAC1
15%
HDAC8
7%
Heavy Meromyosin
8%
Helicase
25%
Hematopoiesis
12%
Hematopoietic Stem Cell
8%
IL1RL1
15%
In Vitro Study
5%
Knockout Mouse
7%
Mouse
65%
Mouse Model
5%
Myeloid
79%
MYH11
51%
Oncogene
6%
P21
15%
P53
11%
PAX5
15%
Phosphoinositide 3-Kinase
5%
Progenitor Cell
7%
Proteasome
15%
RUNX1
100%
RUNX1T1
15%
Stem Cell
6%
Ubiquitin-Conjugating Enzyme
6%
Upregulation
5%
Wild Type
15%
Immunology and Microbiology
Carboxy Terminal Sequence
15%
Cell Activity
7%
Cell Cycle
7%
Cell Cycle Arrest
5%
Cell Population
7%
Cell Proliferation
7%
Cell Survival
17%
Chimeric Antigen Receptor T-Cell
12%
Chimeric Antigen Receptor T-Cell Therapy
6%
Chromosome 16
13%
Core Binding Factor
15%
Core Binding Factor Beta
37%
DNA Binding Protein
13%
DNA Damage
5%
DNA Synthesis
5%
Fusion Gene
8%
Gene Expression
7%
Genetically Engineered Mouse Strain
5%
Heavy Chain
7%
Hematopoietic Cell
5%
Hematopoietic Stem Cell
5%
Human Papillomavirus Type 16
5%
Immunocompetent Cell
15%
Immunotherapy
15%
Interleukin-33
7%
Knockout Mouse
11%
Leukemia Cell
6%
Mitochondrial Respiration
15%
Mouse
76%
Multi-Omics
15%
Myeloid
70%
Oncogene
5%
P53
15%
Polyinosinic:polycytidylic Acid
5%
Smooth Muscle
7%
Stem Cell
15%
Transgenic Mouse
5%
Upregulation
7%
Wart Virus
5%
